; (3) a description of the collaboration and coordination of United States anti-tuberculosis efforts with the World Health Organization, the Global Fund, and other major public and private entities; (4) a description of the collaboration and coordination among the United States Agency for International Development and other United States agencies, including the Centers for Disease Control and the Office of the Global AIDS Coordinator, for the purposes of combatting tuberculosis; (5) the constraints on implementation of programs posed by health workforce shortages, heath system limitations, and other capacities; (6) the numbers of people trained by the United States Government in tuberculosis surveillance and control; (7) a breakdown of expenditures for direct patient tuberculosis services, drugs and other commodities, drug management, training in diagnosis and treatment, health systems strengthening, research, and support costs; and (8) for each country receiving bilateral United States assistance for the purpose of tuberculosis prevention, treatment, and control— (A) a description of progress to adopt and implement the most recent World Health Organization guidelines to improve diagnosis, treatment, and prevention of tuberculosis for adults and children, disaggregated by sex, including the proportion of health facilities which have adopted the latest WHO guidelines on strengthening surveillance systems and preventative, diagnostic, and therapeutic methods, including the use of rapid diagnostic tests and orally administered TB treatment regimens; (B) the rate of tuberculosis incidence for adults and children, disaggregated by sex, and a description of progress in implementing measures to reduce incidence, including the number of adults and children receiving tuberculosis preventive therapy, including people with HIV and all close contacts, disaggregated by sex, and the establishment of effective tuberculosis infection control in all congregant settings, including hospitals, clinics, and prisons